Applied Therapeutics Inc APLT:NASDAQ

Set AlertOptionsStreaming Charts
Last Price$3.06NASDAQ Previous Close - Last Trade as of 3:57PM ET 1/26/22

Today's Change-0.25(7.55%)
Bid (Size)$2.27 (1)
Ask (Size)$4.20 (1)
Day Low / High$3.01 - 3.36
Volume298.2 K
Sell
Buy
Chart Style Historical Chart Icon Download historical data
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 01/26/2022

Timeframe
 

Applied Therapeutics Inc ( NASDAQ )

Price: $3.06
Change: -0.25 (7.55%)
Volume: 298.2 K
3:57PM ET 1/26/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

CASI Pharmaceuticals Inc ( NASDAQ )

Price: $0.62
Change: -0.008 (1.34%)
Volume: 529.5 K
3:57PM ET 1/26/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

Trevena Inc ( NASDAQ )

Price: $0.51
Change: -0.01 (2.70%)
Volume: 675.1 K
3:57PM ET 1/26/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

AVROBIO Inc ( NASDAQ )

Price: $1.84
Change: -0.07 (3.66%)
Volume: 439.1 K
3:57PM ET 1/26/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain
 

Capricor Therapeutics Inc ( NASDAQ )

Price: $3.20
Change: -0.24 (6.98%)
Volume: 472.00
3:56PM ET 1/26/2022
 
Sell
Buy
Detailed Quote|Set Alert|Options Chain

Read more news Recent News

--Citigroup Adjusts Applied Therapeutics' Price Target to $30 From $38, Reiterates Buy Rating
11:24AM ET 1/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Goldman Sachs Adjusts Price Target on Applied Therapeutics to $3 From $10, Reiterates Sell Rating
8:29AM ET 1/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Barclays Downgrades Applied Therapeutics to Equalweight From Overweight, Slashes Price Target to $7 From $44
7:46AM ET 1/04/2022 MT Newswires

Applied Therapeutics (APLT) has an average investment rating of outperform and price targets ranging from $7 to $85, according to analysts polled by...

Sector Update: Health Care Stocks Finishing Lower in Monday Trading
4:04PM ET 1/03/2022 MT Newswires

Health care stocks trimmed a portion of its Monday retreat this afternoon, with the NYSE Health Care Index falling 1.1% while the SPDR Health Care Select...

View all Commentary and Analysis

Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock
8:35AM ET 1/19/2022 Seeking Alpha

Wall Street Breakfast: What Moved Markets
5:57AM ET 1/08/2022 Seeking Alpha

Company Profile

Business DescriptionApplied Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY. View company web site for more details
Address545 5th Avenue
New York, New York 10017
Phone+1.212.220.9226
Number of EmployeesN/A
Chairman, President, CEO & SecretaryShoshana Shendelman
CFO & Head-Business DevelopmentCharles Silberstein
Chief Medical OfficerRiccardo Perfetti
Chief Commercial OfficerAdam Hansard

Company Highlights

Price Open$3.35
Previous Close$3.06
52 Week Range$2.87 - 29.80
Market Capitalization$80.2 M
Shares Outstanding26.2 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement03/17/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$4.13
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-98.12%

Analyst Ratings as of 12/31/2021

Buy
4
Overweight
1
Hold
1
Underweight
0
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset